Venus Remedies Ltd (VENUSREM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Venus Remedies Ltd (VENUSREM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3326
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Venus Remedies Ltd (Venus) is a pharmaceutical company that develops, manufactures and commercializes research, herbal and generic products. The company’s manufactures products for analgesic and antipyretic, antibiotic, anticoagulant, disinfectant and antiseptic, iron supplement, neurology, respiratory, oncology, and vitamins supplements. Venus is also engaged in research of Antimicrobial Resistance (AMR), a resistance which works against the microorganisms such as viruses (HIV), bacteria (causes pneumonia), and some parasites (Malaria). The company operates through its injectable manufacturing units located in Panchkula and Baddi, India; and Werne, Germany. Venus is headquartered in Panchkula, Haryana, India.

Venus Remedies Ltd (VENUSREM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Venus Remedies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Venus Remedies Enters into Agreement with Teva Pharma for Anti Cancer Drug 11
Venus Pharma Enters Into Co-Marketing Agreement With Mylan For Meropenem 12
Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 13
Licensing Agreements 14
Venus Remedies May Enter into Licensing Agreement with Europe and US Company 14
Venus Remedies to Enter into License Agreement with Austell Lab for Elores 15
Venus Pharma Enters into Licensing Agreement with Mylan for Meropenem 16
Venus Remedies Enters Into Licensing Agreement With Goodwills For Elores 17
Equity Offering 18
Venus Remedies Withdraws Private Placement of Shares 18
Venus Remedies Plans Private Placement Of Shares For Up To US$30 Million 19
Asset Transactions 20
China Medical System Acquires Six Products from Venus Pharma 20
Venus Remedies Ltd – Key Competitors 21
Venus Remedies Ltd – Key Employees 22
Venus Remedies Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
May 30, 2017: Venus Remedies Reports Total Income Of INR4 Billion In Fiscal 2017 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Venus Remedies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Venus Remedies Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Venus Remedies Enters into Agreement with Teva Pharma for Anti Cancer Drug 11
Venus Pharma Enters Into Co-Marketing Agreement With Mylan For Meropenem 12
Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 13
Venus Remedies May Enter into Licensing Agreement with Europe and US Company 14
Venus Remedies to Enter into License Agreement with Austell Lab for Elores 15
Venus Pharma Enters into Licensing Agreement with Mylan for Meropenem 16
Venus Remedies Enters Into Licensing Agreement With Goodwills For Elores 17
Venus Remedies Withdraws Private Placement of Shares 18
Venus Remedies Plans Private Placement Of Shares For Up To US$30 Million 19
China Medical System Acquires Six Products from Venus Pharma 20
Venus Remedies Ltd, Key Competitors 21
Venus Remedies Ltd, Key Employees 22
Venus Remedies Ltd, Other Locations 23
Venus Remedies Ltd, Subsidiaries 23

List of Figures
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Venus Remedies Ltd (VENUSREM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Comstock Resources Inc (CRK):企業の財務・戦略的SWOT分析
    Summary Comstock Resources Inc (Comstock) is an oil and gas company. It acquires, develops, explores and produces oil and natural gas properties. The company provides oil and gas operations such as Eagle ford Shale, Haynesville Shale and Bakken Shale in North Dakota and Montana; and North Louisiana, …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Immunomic Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Immunomic Therapeutics Inc (ITI) is a clinical-stage biotechnology company that develops patented lysosomal-associated membrane protein or lamp technology based nucleic acid immunotherapy platforms. The company’s vaccines utilize the body’s natural biochemistry to develop immune response inc …
  • Shanghai Pharmaceutical Co Ltd (601607):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler and distributor of healthcare products. The company carries out the research and development, manufacture and sale of pharmaceutical products for treating HER2 positive advanced breast cancer, systemic a …
  • MicroStrategy Inc (MSTR):企業の財務・戦略的SWOT分析
    MicroStrategy Inc (MSTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Otto Bock HealthCare GmbH:企業の戦略的SWOT分析
    Otto Bock HealthCare GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Aurigene Discovery Technologies Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Aurigene Discovery Technologies Ltd (Aurigene), a subsidiary of Dr. Reddy's Laboratories Ltd, is a biotechnology company that develops small molecule and peptide therapeutics. The company develops small molecule and peptide drug candidates for oncology and inflammatory diseases. It owns inte …
  • Pathfinder Energy Pty Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Pathfinder Energy Pty Ltd (Pathfinder) is an oil and gas company that offers exploration and development of conventional and unconventional oil and gas resources. The company acquires exploration permits and matures prospects using geophysics and geology. It maintains exploration licenses in …
  • The NorInchukin Bank:企業の戦略・SWOT・財務情報
    The NorInchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The NorInchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Incyte Corp (INCY):製薬・医療:M&Aディール及び事業提携情報
    Summary Incyte Corp (Incyte) is a biopharmaceutical company that discovers, develops, and commercializes proprietary cancer therapeutics. The company’s lead product, Jakafi (ruxolitinib) is marketed in the US for the treatment of patients with high-risk myelofibrosis as well as patients with polycyt …
  • Lindsay Corporation:企業の戦略・SWOT・財務情報
    Lindsay Corporation - Strategy, SWOT and Corporate Finance Report Summary Lindsay Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Landstar System Inc (LSTR):企業の財務・戦略的SWOT分析
    Landstar System Inc (LSTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Akorn Inc (AKRX):企業の財務・戦略的SWOT分析
    Akorn Inc (AKRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • P. H. Glatfelter Company (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Company (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sanford Health-製薬・医療分野:企業M&A・提携分析
    Summary Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center’s medical services include allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding disorders, botox …
  • Actividades de Construccion y Servicios SA:戦略・SWOT・企業財務分析
    Actividades de Construccion y Servicios SA - Strategy, SWOT and Corporate Finance Report Summary Actividades de Construccion y Servicios SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • American Woodmark Corp (AMWD):企業の財務・戦略的SWOT分析
    American Woodmark Corp (AMWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Resources Connection Inc (RECN):企業の財務・戦略的SWOT分析
    Summary Resources Connection Inc (Resources Connection) operates as a consultancy firm that offers consulting and business initiative support services. The firm offers services such as change management, finance and accounting services, merger and acquisition transaction services, program and projec …
  • VIDA Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary VIDA Diagnostics Inc (VIDA) is a medical technology company that provides clinical imaging software and analysis services for early detection, evaluation, and treatment of pulmonary diseases. The company offers VIDA exchange and VIDA vision. Its products are used in airway mapping, lung volu …
  • Dril-Quip Inc (DRQ):企業の財務・戦略的SWOT分析
    Dril-Quip Inc (DRQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆